Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1112.70 13.15 (1.20%) | NSE 1111.70 12.30 (1.12%) | Trade | Add

BSE Live

Oct 29, 16:01

1112.70 13.15 (1.20%)

Volume

AVERAGE VOLUME

5-Day

12,770

10-Day

17,649

30-Day

27,479

230,562

Prev. Close

1099.55
Open Price

1100.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 29, 15:59

1111.70 12.30 (1.12%)

Volume

AVERAGE VOLUME

5-Day

853,060

10-Day

943,061

30-Day

1,252,387

1,369,659

Prev. Close

1099.40
Open Price

1104.00

Bid Price (Qty.)
1111.70 (91)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Aurobindo Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	12,934.53	11,938.70	10,041.96	9,539.36	9,078.96
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	33.25	174.16	156.58
Revenue From Operations [Net]	12,934.53	11,938.70	10,008.71	9,365.20	8,922.38
Total Operating Revenues	13,266.48	12,257.89	10,269.90	9,607.05	9,166.18
Other Income	403.37	199.22	80.65	135.95	188.36
Total Revenue	13,669.85	12,457.11	10,350.55	9,743.00	9,354.54
EXPENSES
Cost Of Materials Consumed	6,747.55	6,455.30	4,893.27	4,604.19	4,425.80
Purchase Of Stock-In Trade	5.51	14.25	3.72	11.21	6.31
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-229.53	-289.80	-337.20	31.32	-141.59
Employee Benefit Expenses	1,561.47	1,362.77	1,131.64	927.30	807.05
Finance Costs	240.94	230.86	52.89	45.16	229.31
Depreciation And Amortisation Expenses	470.48	413.03	354.83	286.17	263.00
Other Expenses	2,495.73	2,306.08	1,908.46	1,659.08	1,616.82
Total Expenses	11,292.15	10,492.49	8,007.61	7,564.43	7,206.70
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	2,377.70	1,964.62	2,342.94	2,178.57	2,147.84
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	2,377.70	1,964.62	2,342.94	2,178.57	2,147.84
Tax Expenses-Continued Operations
Current Tax	505.86	426.61	505.34	462.06	518.23
Less: MAT Credit Entitlement	0.00	48.05	43.32	64.28	0.00
Deferred Tax	-0.90	56.33	68.15	74.03	2.91
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	504.96	434.89	530.17	471.81	521.14
Profit/Loss After Tax And Before ExtraOrdinary Items	1,872.74	1,529.73	1,812.77	1,706.76	1,626.70
Profit/Loss From Continuing Operations	1,872.74	1,529.73	1,812.77	1,706.76	1,626.70
Profit/Loss For The Period	1,872.74	1,529.73	1,812.77	1,706.76	1,626.70
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	31.96	26.11	30.94	29.16	27.85
Diluted EPS (Rs.)	31.96	26.11	30.94	29.16	27.85
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	15.15
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	122.76
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	175.78	146.48	219.71	114.11	134.37
Tax On Dividend	9.66	13.86	44.73	23.23	27.36
Equity Dividend Rate (%)	300.00	250.00	250.00	250.00	250.00